Handelsavisen
prelaunch
Companies Healthcare 188260.KQ
18
188260.KQ KOSDAQ Medical Equipment, Supplies & Distribution

188260.Kq

$1 589,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-28,5 %
ROE
-235,0 %
Net margin
-37,9 %
Debt / equity
1,05
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies, generating revenue through sales and related services.

Business. The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies, generating revenue through sales and related services.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-235,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 188260.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 188260.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    The company operates in the healthcare services and equipment industry, primarily engaged in the distribution of medical equipment and supplies, generating revenue through sales and related services.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    The company's capital structure is characterized by a debt-to-equity ratio of 1.05, indicating a moderate reliance on debt financing. Its liquidity position is assessed as medium, with a current ratio of 1.63, suggesting the company has sufficient short-term assets to cover its short-term liabilities, but with limited excess. The company holds KRW 1,582,608,830 in cash and equivalents, but this is offset by long-term debt of KRW 2,593,760,910, resulting in a net cash position that is negative after subtracting total debt.

    Profitability metrics are weak, with a return on equity of -2.35 and a return on assets of -0.5756, both significantly below the industry median. The company reported a net loss of KRW 5,820,380,450 and an operating loss of KRW 4,374,487,150, indicating a challenging operating environment. Gross profit of KRW 3,109,424,950 is insufficient to cover operating expenses, contributing to the negative returns.

    The company's revenue is concentrated in a single disclosed segment, with no geographic breakdown provided in the available data. This lack of diversification increases exposure to regional economic or regulatory shifts. The absence of segment or geographic detail limits the ability to assess risk from over-reliance on a specific market or product line.

    Growth trajectory is negative, with the company reporting declining operating and net income. The operating cash flow is negative at KRW -4,179,389,300, and free cash flow is also negative at KRW -5,093,781,990. Capital expenditures of KRW -210,875,190 suggest some investment in infrastructure, but the overall cash flow position indicates a lack of capacity for meaningful growth initiatives.

    Risk factors include liquidity constraints and a high debt burden, which could limit the company's ability to respond to market changes or invest in growth. The risk assessment indicates a low probability of dilution, but the company's negative cash flow and operating losses suggest a need for potential capital raising in the near term. The absence of disclosed dilution sources in the available data does not rule out future equity issuance.

    Recent events include the filing of financial results showing continued losses and negative cash flows. No recent transcripts or filings beyond the financial snapshot are available in the provided data, limiting insight into management commentary or strategic direction.

    Key takeaways
    • The company is operating at a loss with negative returns on equity and assets.
    • Liquidity is moderate, but the company has a negative net cash position after accounting for long-term debt.
    • Revenue is concentrated in a single segment, with no geographic diversification disclosed.
    • Growth is constrained by negative operating and free cash flows.
    • The company faces significant financial risk due to its high debt load and weak profitability.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Valuation

    Market price
    $1 589,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $2.48B
    Net cash
    -$1.01B
    Current ratio
    1.6
    Debt / equity
    1.1
    ROA
    -57.6%
    ROE
    -2.4%
    Cash conversion
    72.0%
    CapEx / revenue
    -1.4%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-28,5 %Bottom quartile
    Net Margin-37,9 %Bottom quartile
    ROE-235,0 %Bottom quartile
    Capex / Rev-1,4 %Above P75
    D/E1,05Bottom quartile
    Cash Conv0,72Below median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • 188260.KQ Market data — financials · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    188260.KQCanonical
    KOSDAQ · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    — missing data
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage